EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
17.07
+1.74 (11.35%)
At close: Feb 23, 2026, 4:00 PM EST
17.19
+0.12 (0.72%)
Pre-market: Feb 24, 2026, 8:17 AM EST

EyePoint Revenue

EyePoint had revenue of $966.00K in the quarter ending September 30, 2025, a decrease of -90.82%. This brings the company's revenue in the last twelve months to $42.34M, down -7.38% year-over-year. In the year 2024, EyePoint had annual revenue of $43.27M, down -5.97%.

Revenue (ttm)
$42.34M
Revenue Growth
-7.38%
P/S Ratio
33.38
Revenue / Employee
$256,600
Employees
165
Market Cap
1.41B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202443.27M-2.75M-5.97%
Dec 31, 202346.02M4.61M11.14%
Dec 31, 202241.40M4.47M12.09%
Dec 31, 202136.94M2.50M7.27%
Dec 31, 202034.44M14.07M69.10%
Dec 31, 201920.37M15.79M345.53%
Dec 31, 20184.57M1.61M54.37%
Sep 30, 20182.96M--
Jun 30, 20182.96M--
Dec 31, 20172.96M-4.58M-60.72%
Jun 30, 20177.54M--
Dec 31, 20167.54M5.92M365.37%
Jun 30, 20161.62M--
Dec 31, 20151.62M-24.95M-93.90%
Jun 30, 201526.57M23.09M664.90%
Jun 30, 20143.47M1.33M62.06%
Jun 30, 20132.14M-1.38M-39.22%
Jun 30, 20123.53M-1.44M-28.98%
Jun 30, 20114.97M-18.09M-78.46%
Jun 30, 201023.05M10.89M89.55%
Jun 30, 200912.16M8.69M249.88%
Jun 30, 20083.48M1.69M94.73%
Jun 30, 20071.79M749.00K72.30%
Jun 30, 20061.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Geron183.40M
Day One Biopharmaceuticals133.67M
Immatics99.45M
Septerna22.05M
Inventiva19.93M
Nanobiotix11.93M
Taysha Gene Therapies6.31M
DBV Technologies5.50M
Revenue Rankings